Immix Biopharma, Inc. IMMX
10.97
(0.73)
(6.24%)
as of 25 Sep
- Market cap
- $844.3M
- P/E
- 0.0×
Follow IMMX
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
25.13 | 8.76 | 10.01 | 1.53 |
+8 more quarters Free account |
Net Debt/EBITDA |
18.83 | 8.49 | 9.29 | 2.12 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.02 | 0.97 | 1.03 | 0.78 | |
Capex/Depreciation |
(0.16) | (0.25) | (1.82) | (2.76) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.18) | (0.18) | (0.34) | (0.20) | |
Cash per Share |
3.64 | 1.64 | 3.05 | 0.50 | |
Shareholders Equity per Share |
3.59 | 1.52 | 2.85 | 0.26 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.59 | 1.52 | 2.85 | 0.26 | |
Free Cash Flow |
(11.76) | (9.86) | (11.19) | (6.28) | |
Working Capital |
224.49 | 81.74 | 91.13 | 5.73 | |
Capital Expenditures |
(0.02) | (0.03) | (0.17) | (0.37) | |
Net Current Asset Value |
223.60 | 80.82 | 90.19 | 4.77 | |
| Other line items | |||||
Quick Ratio |
24.95 | 8.59 | 9.93 | 1.47 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.18) | (0.18) | (0.33) | (0.18) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | |
Average Payables |
9.56 | 9.83 | 9.30 | 8.61 | |
Average Assets |
127.37 | 57.85 | 63.89 | 22.61 | |
Average Common Equity |
116.78 | 46.98 | 53.52 | 12.91 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates